Recent advances in HIV prevention, including the introduction of lenacapavir as a twice-yearly injectable, are transforming the landscape of global health. At the same time, contentious appointments and policy reversals in public health agencies are fueling polarization and concern among experts. These developments highlight the urgent need for evidence-based decision-making and sustained advocacy to address persistent health threats.
Bluesky
#public health
#medical innovation
#health policy
#advocacy
#global health